Our results suggest that chemogenetic inhibition of TRPV1+ neurons is not sufficient to reduce DSS-induced colitis, whereas CNO stimulation induces neurogenic inflammation in the colon, highlighted by TNF-α, IL-1β, or IL-6 upregulation. This evidence concerns the gene IL1B and colitis.